On Windows 11, the mouse is an essential tool for navigating and performing actions with ease. To ensure the best experience, it’s important to optimize its settings to match your preferences.

Maddy Myers has run Polygon’s games section since 2020 as deputy editor. She has worked in games journalism since 2007, at Kotaku, The Mary Sue, and the Boston Phoenix. Nintendo has finally ...

Why it matters: After a decade of robust growth from 2011 to 2021, the gaming industry has hit a plateau, creating a climate of caution and reduced investment. However, amidst this stagnation ...

After the Nintendo Switch 2 reveal this morning, those rumors that you might be able to use your Joy-Con as a mouse are looking preeeeeeeeeetty good. During the reveal trailer, there's a moment ...

It’s a mouse that we see discounted fairly often, but it’s now back to near-record lows on Amazon, with a huge $72 off its standard MSRP. This Logitech gaming mouse deal right now isn’t one ...

In addition, this debut look at the successor seemingly confirms that the Joy-Con controllers will indeed include mouse functionality. A brief segment of the footage shows both Joy-Con moving ...

Years ago, Microsoft CEO Satya Nadella decided to buy some pricey game studios to try to prop up the tech giant's gaming division. Now, the company is saying goodbye to more staff.

Exclusive: CNN obtains videos showing new angles of DC plane crash ...

Ah, the scorpion lollipop, a symbol of the Sonoran Desert. I like them, if only for the campiness of the dark, goth-looking scorpion encased unhappily in a gentle green, pink or blue. That said, ...

It appears that this will allow gamers to turn their Joy-Cons into a mouse akin to what you’d use on a computer. If this is true, this would be a massive boon for one particular Nintendo title ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...